Besivance

Active Ingredient(s): Besifloxacin
FDA Approved: * May 28, 2009
Pharm Company: * BAUSCH AND LOMB
Category: Vision / Eye Health

Besifloxacin (INN/USAN) is a fourth-generation fluoroquinolone antibiotic. The marketed compound is besifloxacin hydrochloride. It was developed by SSP Co. Ltd., Japan, and designated SS734. SSP licensed U.S. and European rights to SS734 for ophthalmic use to InSite Vision Incorporated (OTC Pink: INSV) in 2000. InSite Vision developed an eye drop formulation (ISV-403) and conducted preliminary clinical trials before selling the product and all rights to Bausch & Lomb in 2003.[1&am... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Besivance 6 mg/ml Ophthalmic Suspension

NDC: 24208-446

Labeler:

Bausch & Lomb Incorporated

Besivance 6 mg/ml Ophthalmic Suspension

NDC: 50090-1241

Labeler:

A-s Medication Solutions

Besivance 6 mg/ml Ophthalmic Suspension

NDC: 54868-6282

Labeler:

Physicians Total Care, Inc.